Non-depleting CD4-specific monoclonal antibodies for the treatme

Details Non-depleting CD4-specific monoclonal antibodies for the treatme Non-depleting CD4-specific monoclonal antibodies for the treatme

1995-05-08

1997-09-23

Loring, Susan A.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

4241451, 4241581, 4241431, 53038875, 53038824, A61K 39395, C07K 1618, C07K 1624, C07K 1626

Patent

active

056701500

ABSTRACT:
Non-depleting CD4 monoclonal antibodies may be used in the treatment of insulin-dependent diabetes mellitus.

REFERENCES:
Waldmann, Herman, Immunology Today, 14(6):247-251, 1993.
Waldmann, T.A, Science, 252: 1657-1662, Jun. 1991.
Varey, A.M et al., (Autoimmunity), Biochem Soc. Transactions, 19:187-191.
Shizuru, J.A. et al., Science, 240: 659-662, 29 Apr. 1988.
Charlton, B. et al., Autoimmunity ) 4:1-7, 1989.

Affiliated with

Also associated with

Rating

Non-depleting CD4-specific monoclonal antibodies for the treatme does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-depleting CD4-specific monoclonal antibodies for the treatme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-depleting CD4-specific monoclonal antibodies for the treatme will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1937834